Glenmark Specialty competitive analysis

Latest publications and patents of Glenmark Specialty New

Explore the latest publications and patents granted to Glenmark Specialty, showcasing their recent innovations and technological advancements.

Last updated on: Sep 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Glenmark Specialty

Jun 30, 2021Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone And OlopatadineGranted And Under Opposition

Explore Glenmark Specialty's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 30, 2021Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone And Olopatadine1

Latest PTAB cases involving Glenmark Specialty

Discover the latest PTAB cases involving Glenmark Specialty, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glenmark Specialty with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
GLENMARK SPECIALTY - 1 - - Non-Active
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB20 - - - Highly Aggressive